Announced development of SL-325, a first-in-class antagonist antibody to DR3, the receptor for TL1A; IND filing expected in Q3'2025 – – Cash balance of approximately $90M as of September 30, 2024; ...

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); top-line data readout is on track for the end of the first ...

In sarcoidosis, elevated inflammatory proteins in plasma are evident years before the onset of disease, according to study findings published in the European Respiratory Journal.

ILTs along with KIRs constitute the immunoglobulin-like receptor superfamily. Another group of receptors are the C-type lectin superfamily, which consists of a disulfide-linked heterodimer of CD94 ...

Beyond the score: The sports world explained. The Sporting News has been a trusted sports media publisher since 1886, delivering the news, insights and entertainment that fans around the world ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, California, USA Correspondence to Dr Michael ...